News
GPs could face a rise in prescribing and monitoring work under draft NICE guidelines recommending earlier use of newer type 2 ...
In a significant development for weight management, the Food and Drug Administration (FDA) announced Wednesday its approval ...
The manufacturer of Ozempic (and other Semaglutide brands) faces over $2 billion in lawsuits filed by over 1,800 patients claiming blindness, stomach paralysis, and more.
The decision comes after evidence suggested these drugs protect the heart and kidneys as well as controlling blood sugar, Nice said. It is estimated the change could save almost 22,000 lives once ...
MBX Biosciences Inc. (NASDAQ: MBX) is one of the best IPO stocks to buy according to Wall Street analysts. On June 16, MBX ...
Columnist Teri Sforza writes that studies have found that the popular weight-loss and diabetes drugs reduced alcohol intake, ...
Columnist Teri Sforza writes that studies have found that the popular weight-loss and diabetes drug reduced alcohol intake, ...
Novo Nordisk lowers Ozempic cost to $499 per month for uninsured U.S. patients, expanding access through NovoCare and 70,000 ...
Columnist Teri Sforza writes that studies have found that semaglutide reduced alcohol intake, binge drinking and relapse ...
What To Know: Under the agreement, all strengths of the medications will now be available to eligible self-paying patients at $499 per month through GoodRx's platform.
America’s obesity crisis extends beyond humans — studies suggest that around 60% of dogs and cats nationwide are overweight.
Last year, GLP-1s dominated many employer conversations as demand surged and pressure mounted from employees clamoring for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results